Introducing Sheffield Thornbury Private and International Patient Gamma Knife Service
Book a call with an Amethyst Specialist today:
Book a call with an Amethyst Specialist today:
Gamma Knife is not a knife in the normal sense of the word
No incisions are made in your head Instead, very precisely focused beams of radiation are directed to the treatment area in the brain, optimised to hit only the target without damaging surrounding healthy tissue.
It offers a safe and effective treatment for more than 80,000 patients worldwide every year. The treatment procedure is simple, painless and straightforward.
Mr Matthias Radatz and Mr Jeremy Rowe lead the Thornbury Gamma Knife Radiosurgery Centre in Sheffield welcoming referrals for Privately funded treatment. Offering quick and simple access to life-saving, life-extending treatment to ensure enhanced quality of life for patients under the care and supervision of world-class experts.
Neurosurgeon
Mr Matthias Radatz, formerly Clinical Director for the National Centre for Stereotactic Radiosurgery at the Sheffield Royal Hallamshire Hospital 2013 – 2021; was elected as Chairman of the Stereotactic Radiosurgery Clinical Reference Group in 2013. Mr Radatz has been a Consultant Neurosurgeon and Fellow of the Royal College of Surgeons for 23 years. He has a special interest in both Stereotactic Radiosurgery and Stereotactic Functional Neurosurgery, here at the Thornbury Radiosurgery Centre.
Neurosurgeon
Mr Jeremy Rowe completed a specialist Medical Research Council fellowship using magnetic resonance techniques and his specialist neurosurgical training in Oxford. Mr Rowe has completed several thousand GammaKnife radiosurgery treatments and has gained international recognition as a lecturer and tutor in GammaKnife Stereotactic Radiosurgical practice. Since 2018, his clinical practice has become exclusively stereotactic radiosurgery.
Thornbury Radiosurgery Centre is delighted to offer a dedicated Private Patient and International Referral Treatment Service for the following conditions:
(including secondary metastatic brain tumours which have spread from the body)
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy